Articles related to GLYCEMIC CONTROL

A randomized controlled trial involving 108 adults with metabolic syndrome found that implementing an 8- to 10-hour time-restricted eating window, in addition to standard-of-care treatments, resulted in a 0.10% reduction in HbA1c levels compared to standard care alone.

Ozempic (semaglutide) offers effective glycemic control and weight loss benefits for type 2 diabetes patients, but comes with a range of potential side effects. Physicians should be prepared to discuss common gastrointestinal issues, rare but serious complications, and special considerations for pregnant or postmenopausal patients.

Recent studies indicate that stevia, unlike some artificial sweeteners, does not increase appetite or decrease satiety, potentially aiding in weight management efforts.

New guidelines endorse the use of continuous glucose monitors and insulin pumps in hospital settings, potentially improving glycemic control while reducing hypoglycemia risk in noncritically ill patients.

Recent studies suggest a strong link between high sugar intake and increased risk of pancreatic cancer, emphasizing the need for dietary counseling in cancer prevention strategies.

A diet high in soluble fiber, protein, and healthy fats can mimic the effects of GLP-1 agonists like Ozempic, offering a safer alternative for weight management and metabolic health.